Table 2.
Control | Alzheimer | Alcoholic | |||
---|---|---|---|---|---|
MRI | corpus callosum height (mm) | 26 ± 3 | 29 ± 5 | 26 ± 4 | |
corpus callosum length (mm) | 74 ± 4 | 76 ± 7 | 73 ± 5 | ||
Total corpus callosum area (mm2) | 406 ± 43 | 364 ± 38 | 370 ± 28 | ||
Genu area (mm2) | 84 ± 14 | 68 ± 13 | 69 ± 9 | ||
Body area (mm2) | 194 ± 27 | 186 ± 36 | 177 ± 22 | ||
Splenium area (mm2) | 129 ± 16 | 110 ± 10 | 124 ± 17 | ||
Lateral ventricles volume (cm3) | 25 ± 9 | 60 ± 27 | 35 ± 18 | ||
DTI | Total corpus callosum | FA | 0.48 ± 0.03 | 0.41 ± 0.04 | 0.44 ± 0.04 |
MD | 0.60 ± 0.05 | 0.70 ± 0.06 | 0.66 ± 0.06 | ||
Genu | FA | 0.44 ± 0.05 | 0.36 ± 0.05 | 0.39 ± 0.04 | |
FA: rarefied sample | 0.64 ± 0.09 | 0.49 ± 0.07 | 0.53 ± 0.09 | ||
MD (10−3 mm2 /s) | 0.60 ± 0.07 | 0.72 ± 0.09 | 0.66 ± 0.07 | ||
MD (10−3mm2 /s): rarefied sample | 0.58 ± 0.09 | 0.77 ± 0.10 | 0.68 ± 0.09 | ||
Body | FA | 0.46 ± 0.04 | 0.38 ± 0.04 | 0.41 ± 0.04 | |
MD (10−3 mm2/s) | 0.62 ± 0.56 | 0.73 ± 0.07 | 0.70 ± 0.06 | ||
Splenium | FA | 0.55 ± 0.04 | 0.49 ± 0.05 | 0.51 ± 0.05 | |
FA: rarefied sample | 0.80 ± 0.07 | 0.80 ± 0.06 | 0.80 ± 0.07 | ||
MD (10−3mm2/ s) | 0.56 ± 0.05 | 0.62 ± 0.06 | 0.59 ± 0.07 | ||
MD (10−3mm2 /s): rarefied sample | 0.48 ± 0.05 | 0.49 ± 0.05 | 0.48 ± 0.06 |